Donald R. Britton

2.3k total citations
34 papers, 1.9k citations indexed

About

Donald R. Britton is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Behavioral Neuroscience. According to data from OpenAlex, Donald R. Britton has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 8 papers in Behavioral Neuroscience. Recurrent topics in Donald R. Britton's work include Receptor Mechanisms and Signaling (15 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Neuroscience and Neuropharmacology Research (11 papers). Donald R. Britton is often cited by papers focused on Receptor Mechanisms and Signaling (15 papers), Neurotransmitter Receptor Influence on Behavior (15 papers) and Neuroscience and Neuropharmacology Research (11 papers). Donald R. Britton collaborates with scholars based in United States, United Kingdom and Canada. Donald R. Britton's co-authors include George F. Koob, M.L. Vale, J. Rivier, Karen T. Britton, John W. Kebabian, Kazumi Shiosaki, Karen E. Asin, Robert Schoenleber, Pierre J. Blanchet and Michael P. DeNinno and has published in prestigious journals such as Neurology, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Donald R. Britton

34 papers receiving 1.8k citations

Peers

Countries citing papers authored by Donald R. Britton

Since Specialization

Citations

This map shows the geographic impact of Donald R. Britton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. Britton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. Britton more than expected).

Fields of papers citing papers by Donald R. Britton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. Britton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. Britton. The network helps show where Donald R. Britton may publish in the future.

Co-authorship network of co-authors of Donald R. Britton

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. Britton. A scholar is included among the top collaborators of Donald R. Britton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. Britton. Donald R. Britton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Actions of the D 1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L -dopa-primed common marmosets 1999 ·Psychopharmacology ·R. K. B. Pearce, Michael S. Jackson, Donald R. Britton, Kazumi Shiosaki, Peter Jenner, C. D. Marsden	34
2	Site and event specific increase of striatal adenosine release by adenosine kinase inhibition in rats 1999 ·Neuroscience Letters ·Donald R. Britton, Joe Mikusa, Chih‐Hung Lee, Michael F. Jarvis, Michael Williams, Elizabeth A. Kowaluk	28
3	Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431 1996 ·European Journal of Pharmacology ·Kazumi Shiosaki, Karen E. Asin, Donald R. Britton, William J. Giardina, Lisa Bednarz, Laura Mahan, Joe Mikusa, Arthur L. Nikkel, Carol T. Wismer	17
4	(5aR,11bS)-4,5,5a,6,7,11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintain behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431) 1995 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Stanley DiDomenico, Karen E. Asin, Donald R. Britton, Chun Wel Lin, Michael Williams, Kazumi Shiosaki	51
5	Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys. 1993 ·Journal of Pharmacology and Experimental Therapeutics ·Pierre J. Blanchet, P.J. Bédard, Donald R. Britton, John W. Kebabian	95
6	Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: Comparison with typical and atypical antipsychotics 1992 ·Pharmacology Biochemistry and Behavior ·Donald R. Britton, Peter Curzon, (unknown), Michael Buckley, Michael D. Tufano, Alex M. Nadzan	10
7	A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets 1992 ·European Journal of Pharmacology ·(unknown), Donald R. Britton, Michael P. DeNinno, Richard J. Perner, Lance A. Smith, Peter Jenner, Robert Schoenleber, Michael Williams	129
8	A68930: A potent agonist specific for the dopamine D1 receptor 1992 ·Neurochemistry International ·John W. Kebabian, Michael P. DeNinno, Robert Schoenleber, Robert G. MacKenzie, Donald R. Britton, Karen E. Asin	10
9	A68930: a potent agonist selective for the dopamine D1 receptor 1991 ·European Journal of Pharmacology ·Michael P. DeNinno, Robert Schoenleber, Robert G. MacKenzie, Donald R. Britton, Karen E. Asin, Clark A. Briggs, Joel M. Trugman, (unknown), Linda D. Artman, Lisa Bednarz, Ramesh R. Bhatt, Peter Curzon, (unknown), Chae Hee Kang, (unknown), John W. Kebabian	66
10	Synthesis and pharmacological evaluation of 1-(aminomethyl)-3,4-dihydro-5-hydroxy-1H-2-benzopyrans as dopamine D1 selective ligands 1991 ·Journal of Medicinal Chemistry ·Michael R. Michaelides, Robert Schoenleber, Sheela A. Thomas, (unknown), Donald R. Britton, Robert G. MacKenzie, John W. Kebabian	13
11	Rapid reversal of denervation supersenssitivity of dopamine D1 receptors by 1-dopa or a novel dopamamine D1 receptor agonist, A68930 1991 ·European Journal of Pharmacology ·Donald R. Britton, John W. Kebabian, Peter Curzon	19
12	Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor 1991 ·Journal of Medicinal Chemistry ·Michael P. DeNinno, Robert Schoenleber, Richard J. Perner, (unknown), Karen E. Asin, Donald R. Britton, Robert G. MacKenzie, John W. Kebabian	55
13	Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration 1991 ·Pharmacology Biochemistry and Behavior ·Donald R. Britton, Peter Curzon, Robert G. MacKenzie, John W. Kebabian, Joyce E. Williams, Daniel J. Kerkman	80
14	Effects of 5-HT-1A receptor agonists on CRF-induced behavior 1991 ·Psychopharmacology ·(unknown), Donald R. Britton	21
15	A68930: A Potent and Specific Agonist for the D-1 Dopamine Receptor 1990 ·American Journal of Hypertension ·John W. Kebabian, Clark A. Briggs, Donald R. Britton, Karen E. Asin, Michael P. DeNinno, Robert G. MacKenzie, J.F. McKelvy, Robert Schoenleber	8
16	Central effects of corticotropin releasing factor (CRF): evidence for similar interactions with environmental novelty and with caffeine 1990 ·Psychopharmacology ·Donald R. Britton, (unknown)	13
17	Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor 1989 ·Pharmacology Biochemistry and Behavior ·Donald R. Britton, (unknown), Mary Jane Cullen, James F. Kerwin, Hana Kopecka, Alex M. Nadzan	18
18	Age-related changes in the motor response to environmental novelty in the rat 1989 ·Experimental Gerontology ·(unknown), Manuel F. Varela, A. Garcia, Donald R. Britton	19
19	Effects of ganglionic blocking agents on behavioral responses to centrally administered CRF 1989 ·Brain Research ·Donald R. Britton, (unknown)	32
20	Dexamethasone suppresses pituitary-adrenal but not behavioral effects of centrally administered CRF 1986 ·Life Sciences ·Donald R. Britton, Manuel F. Varela, A. Garcia, M Rosenthal	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact